Stonehage Fleming Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Stonehage Fleming Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,000	Closed	-$552	–	185
2019 Q1	$552	Hold	3,000	–	–	0.03%	96
2018 Q4	$497K	Hold	3,000	–	–	0.03%	106
2018 Q3	$578K	Hold	3,000	–	–	0.03%	103
2018 Q2	$510K	Sell	3,000 -1,000	-25%	-$155K	0.02%	124
2018 Q1	$652K	Hold	4,000	–	–	0.04%	94
2017 Q4	$599K	Hold	4,000	–	–	0.03%	115
2017 Q3	$608K	Hold	4,000	–	–	0.03%	127
2017 Q2	$515K	Hold	4,000	–	–	0.03%	131
2017 Q1	$437K	Hold	4,000	–	–	0.03%	173
2016 Q4	$295K	Sell	4,000 -343	-8%	-$27.9K	0.02%	194
2016 Q3	$379K	Buy	4,343 +343	+9%	+$32.4K	0.02%	160
2016 Q2	$344K	Buy	+4,000	New	+$346K	0.02%	158

Other funds holding VRTX

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return